Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

  • Authors : Li Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.; Wang X

Subjects: Dibenzothiepins*/Dibenzothiepins*/Dibenzothiepins*/adverse effects ; Triazines*/Triazines*/Triazines*/adverse effects ; Oseltamivir*/Oseltamivir*/Oseltamivir*/adverse effects

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 May 09; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 May 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
Academic Journal

Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo.

  • Authors : Lee D; Laboratory of Vitamin C and Antioxidant Immunology, Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.; Jo H

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Zanamivir*/Zanamivir*/Zanamivir*/pharmacology ; Orthomyxoviridae Infections*/Orthomyxoviridae Infections*/Orthomyxoviridae Infections*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2022 Dec 30; Vol. 24 (1). Date of Electronic Publication: 2022 Dec 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol.

  • Authors : Ishiguro N; Division of Infection Control, Hokkaido University Hospital, Nishi 5, Kita 14, Kita-ku, Sapporo, 060-8648, Japan. .; Department of Pediatrics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan. .

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Dibenzothiepins*/Dibenzothiepins*/Dibenzothiepins*/therapeutic use ; Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy

  • Source: BMC infectious diseases [BMC Infect Dis] 2021 Aug 09; Vol. 21 (1), pp. 777. Date of Electronic Publication: 2021 Aug 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
Academic Journal

Urolithin M5 from the Leaves of Canarium album (Lour.) DC. Inhibits Influenza Virus by Targeting Neuraminidase.

  • Authors : Xiao M; School of Life Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China.; Cao F

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/chemistry ; Burseraceae*/Burseraceae*/Burseraceae*/chemistry ; Influenza A Virus, H1N1 Subtype*/Influenza A Virus, H1N1 Subtype*/Influenza A Virus, H1N1 Subtype*/drug effects

  • Source: Molecules (Basel, Switzerland) [Molecules] 2022 Sep 05; Vol. 27 (17). Date of Electronic Publication: 2022 Sep 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

×
Academic Journal

Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs' excretion into the bile and kidney.

  • Authors : Fujiwara K; Department of Applied Life Science, Faculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.; Yamamoto Y

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacokinetics ; Immunohistochemistry/Immunohistochemistry/Immunohistochemistry/*methods ; Oseltamivir/Oseltamivir/Oseltamivir/*analogs & derivatives

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Jun; Vol. 8 (3), pp. e00597.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

تفاصيل العنوان

×
Academic Journal

Synthesis and Biological Evaluation of NH 2 -Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors.

  • Authors : Hu Y; Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. .; Chen B

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*chemical synthesis ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Enzyme Inhibitors/Enzyme Inhibitors/Enzyme Inhibitors/*chemical synthesis

  • Source: Molecules (Basel, Switzerland) [Molecules] 2019 Jun 10; Vol. 24 (11). Date of Electronic Publication: 2019 Jun 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

×
Academic Journal

Anti-pandemic influenza A (H1N1) virus potential of Xilingjiedu capsule in vitro.

  • Authors : Liu XY; State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University Health Science Center, Peking University, Beijing, PR China.; Cao GY

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/pharmacology ; Influenza A Virus, H1N1 Subtype*/Influenza A Virus, H1N1 Subtype*/Influenza A Virus, H1N1 Subtype*/drug effects

  • Source: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2022 Jan; Vol. 35 (1), pp. 123-128.Publisher: Faculty of Pharmacy, University of Karachi Country of Publication: Pakistan NLM ID: 9426356 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients

  • Authors : Demir Önder K; Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.; Seremet Keskin A

Subjects: Adenosine Monophosphate/Adenosine Monophosphate/Adenosine Monophosphate/*analogs & derivatives ; Alanine/Alanine/Alanine/*analogs & derivatives ; Amides/Amides/Amides/*therapeutic use

  • Source: Turkish journal of medical sciences [Turk J Med Sci] 2021 Dec 13; Vol. 51 (6), pp. 2835-2849. Date of Electronic Publication: 2021 Dec 13.Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID: 9441758 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Differences in antibiotic and antiviral use in people with confirmed influenza: a retrospective comparison of rapid influenza PCR and multiplex respiratory virus PCR tests.

  • Authors : Au Yeung V; Department of Infectious Diseases, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia.; Thapa K

Subjects: Multiplex Polymerase Chain Reaction*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: BMC infectious diseases [BMC Infect Dis] 2021 Apr 07; Vol. 21 (1), pp. 321. Date of Electronic Publication: 2021 Apr 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
Academic Journal

Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case report.

  • Authors : Chen R; Department of Infectious Disease, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Post Code 410008, Hunan, China.; Hunan Key Laboratory of Viral Hepatitis, Department of Infectious Disease, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Post Code 410008, Hunan, China.

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*adverse effects ; Influenza, Human/Influenza, Human/Influenza, Human/*drug therapy ; Mental Disorders/Mental Disorders/Mental Disorders/*etiology

  • Source: BMC infectious diseases [BMC Infect Dis] 2019 Mar 04; Vol. 19 (1), pp. 224. Date of Electronic Publication: 2019 Mar 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
  • 1-10 of  2,227 نتائج ل ""Oseltamivir""